Nuclear Imaging Equipment Devices Market is predicted to reach USD 4.533 billion at a CAGR of 5.50% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Nuclear Imaging Equipment Devices Market”.

The nuclear imaging equipment devices market is estimated to register a CAGR of 5.50% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global nuclear imaging equipment devices market - DIGIRAD Corporation, Neusoft Corporation Bartec Technologies Ltd., BCL X-Ray Canada Inc., CANON MEDICAL SYSTEMS CORPORATION, CMR Naviscan, SurgicEye GmbH, TTG Imaging Solutions, LLC., Lucerno Dynamics LLC., Absolute Imaging Inc., Berthold Technologies GmbH & Co.KG, Incom Inc., Koninklijke Philips N.V., GE Healthcare, and Siemens Healthineers AG.

Market Highlights

The global nuclear imaging equipment devices market is accounted to register a CAGR of 5.50% during the forecast period and is estimated to reach USD 4.533 billion by 2032.

Global burdens of chronic illness are increasing, which is a key element propelling the nuclear imaging equipment devices industry growth overall. Additionally, increasing frequency of a number of diseases, including cancer, neurological disorders, metabolic disorders, and cardiovascular problems, necessitating the use of cutting-edge diagnostic technologies for precise diagnosis and treatment. Because it provides useful functional and metabolic information, nuclear imaging is essential for the diagnosis, staging, and ongoing care of various conditions. It is expected that the market for nuclear imaging equipment devices would have previously unheard-of growth prospects due to the increase in chronic illnesses.

Access full report @ https://www.marketresearchfuture.com/reports/nuclear-imaging-equipment-devices-market-16070

Segment Analysis

The global nuclear imaging equipment devices market has been segmented into product, application, and end-user.

On the basis of product, the market is segmented into SPECT Imaging Systems (Hybrid SPECT Imaging Systems, Standalone SPECT Imaging Systems), PET Imaging Systems, and Planar Scintigraphy Imaging Systems. The SPECT imaging systems segment was attributed to holding the largest market share in 2022. The advancement of hybrid SPECT/CT systems, which fuse the functional data from SPECT with the anatomical information from CT scans. Improved diagnostic accuracy will support segmental expansion by enabling more accurate localization and characterisation of anomalies.

Based on application, the global nuclear imaging equipment devices market has been segmented into Oncology, Cardiology, Neurology, and Other Application. The oncology segment was expected to hold the largest market share in 2022. The high incidence and prevalence of cancer, the development of sophisticated systems and radiation oncology, the advantages of early cancer therapy, and growing awareness of early cancer diagnosis are all contributing factors. Public and commercial groups have also taken steps to reduce the risk of cancer. The WHO states that poor diet, smoking, and inactivity are the main causes of death from cancer.

Based on end-user, the global nuclear imaging equipment devices market has been segmented into Hospitals, Imaging Centers, Academic & Research Centers, and Other End Users. The hospitals segment was expected to hold the largest market share in 2022. The potential for segmental expansion will be accelerated by the integration of nuclear imaging equipment devices into the hospital infrastructure to enable smooth workflow and expedited patient care. It is projected that increased investment in advanced nuclear imaging systems by hospitals, such as PET and SPECT scanners, will increase demand for the products because these systems improve diagnostic capabilities and offer comprehensive imaging services.

Regional Analysis

The global nuclear imaging equipment devices market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe nuclear imaging equipment devices market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The nuclear imaging equipment devices market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World nuclear imaging equipment devices market comprises of Middle East, Africa, and Latin America.

The largest market share for nuclear imaging equipment devices was maintained by the North American regional sector driving forces behind the market's development include the rising incidence of cancer, the need for more qualified workers, and R&D centers to create nuclear imaging technology that is patient-centered. The U.S. market for nuclear imaging equipment devices will also expand rapidly because of the rise in the frequency of chronic diseases and the quick uptake of new technologies.

Moreover, the Europe market has been persistently growing over the forecast period because of the growing use of nuclear imaging technology and the release of fresh radiopharmaceuticals for diagnostic purposes. Furthermore, the expansion of the nuclear imaging equipment devices market in the area is anticipated to be further propelled by technical advances in conjunction with innovations in the healthcare industry.

Additionally, Asia Pacific is anticipated to experience the quickest growth over the forecast period. The higher than average incidence of cancer, along with targeted policies and investments in the healthcare industry, are responsible for the growth. Japan has a very developed nuclear medicine industry, and the number of hybrid SPECT/CT experiments has significantly increased in the last several years.

Furthermore, the rest of the world's nuclear imaging equipment devices market is divided into the Middle East, Africa, and Latin America. Few factors are driving the global market expansion in the rest of the world, including the rise in chronic illness prevalence, technology developments, the move toward customized treatment, and the incorporation of telehealth and remote monitoring solutions. In addition, revenue from nuclear imaging equipment devices market will increase as long-term illnesses like cancer, neurological disorders, and cardiovascular issues become more common.

Key Findings of the Study

• The global nuclear imaging equipment devices market is expected to reach USD 4.533 billion by 2032, at a CAGR of 5.50% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market. The growth is driven by the higher than normal incidence of cancer as well as focused policies and investments in the healthcare sector.


• Based on application, the oncology segment was attributed to holding the largest market in 2022, with an approximate market share of 45%.


• DIGIRAD Corporation, Neusoft Corporation Bartec Technologies Ltd., BCL X-Ray Canada Inc., CANON MEDICAL SYSTEMS CORPORATION, CMR Naviscan, SurgicEye GmbH, TTG Imaging Solutions, LLC., Lucerno Dynamics LLC., Absolute Imaging Inc., Berthold Technologies GmbH & Co.KG, Incom Inc., Koninklijke Philips N.V., GE Healthcare, and Siemens Healthineers AG